| Company | Group | |||||||||
| 2018 | 2017 | (R’million) | 2018 | 2017 | ||||||
| 3 | Operating income before impairments and abnormal items | |||||||||
| Operating income has been determined after charging/(crediting): | ||||||||||
| External auditors’ remuneration | 27,6 | 29,9 | ||||||||
| Audit fees | 23,4 | 25,0 | ||||||||
| Other fees and expenses | 4,2 | 4,9 | ||||||||
| Internal auditors’ remuneration | 9,1 | 7,1 | ||||||||
| Depreciation | 593,1 | 552,5 | ||||||||
| Buildings | 62,1 | 57,7 | ||||||||
| Plant, equipment and vehicles | 529,4 | 489,7 | ||||||||
| Capitalised leased assets | 1,6 | 5,1 | ||||||||
| Amortisation | 9,8 | 11,4 | ||||||||
| Trademarks, licence agreements and other intangibles | 9,2 | 10,8 | ||||||||
| Customer lists | 0,6 | 0,6 | ||||||||
| Operating lease charges* | 192,0 | 180,9 | ||||||||
| Land and buildings | 71,9 | 58,4 | ||||||||
| Plant, equipment and vehicles | 120,1 | 122,5 | ||||||||
| Loss on disposal of plant, equipment and vehicles | 0,4 | 5,0 | ||||||||
| Research, development and related expenditure | 62,3 | 16,4 | ||||||||
| IFRS 2 charges | 81,9 | 110,3 | ||||||||
| Cash settled | (3,9) | 12,6 | ||||||||
| Equity settled, including BEE-related IFRS 2 charges | 85,8 | 97,7 | ||||||||
| Staff costs | 3 417,1 | 3 319,2 | ||||||||
| Employer’s contribution to retirement funding | 268,5 | 239,4 | ||||||||
| Employer’s contribution to medical aid | 86,1 | 85,6 | ||||||||
| (2,0) | 0,4 | Foreign exchange (profit)/loss | (11,6) | (17,7) | ||||||
| Rental income and fee income | (5,3) | (11,4) | ||||||||